BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37512140)

  • 1. MicroRNAs as a Potential Biomarker in the Diagnosis of Cardiovascular Diseases.
    Kramna D; Riedlova P; Jirik V
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Aghabozorgi AS; Ahangari N; Eftekhaari TE; Torbati PN; Bahiraee A; Ebrahimi R; Pasdar A
    J Cell Physiol; 2019 Dec; 234(12):21796-21809. PubMed ID: 31273798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs).
    Khan SU; Saeed S; Sheikh AN; Arbi FM; Shahzad A; Faryal U; Lu K
    Curr Probl Cardiol; 2023 Dec; 48(12):102010. PubMed ID: 37544621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: roles in cardiovascular development and disease.
    Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
    Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs in cardiovascular disease - clinical application.
    Schulte C; Karakas M; Zeller T
    Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in cardiovascular disease.
    Siasos G; Bletsa E; Stampouloglou PK; Oikonomou E; Tsigkou V; Paschou SA; Vlasis K; Marinos G; Vavuranakis M; Stefanadis C; Tousoulis D
    Hellenic J Cardiol; 2020; 61(3):165-173. PubMed ID: 32305497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
    Krammer TL; Mayr M; Hackl M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
    Wronska A
    J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA
    Haybar H; Sadati NS; Purrahman D; Mahmoudian-Sani MR; Saki N
    Epigenomics; 2023 Dec; 15(23):1273-1290. PubMed ID: 38088089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insight into Mechanisms of Cardiovascular Diseases: An Integrative Analysis Approach to Identify TheranoMiRNAs.
    Sessa F; Salerno M; Esposito M; Cocimano G; Pisanelli D; Malik A; Khan AA; Pomara C
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and Cardiovascular Disease Risk.
    Searles CD
    Curr Cardiol Rep; 2024 Feb; 26(2):51-60. PubMed ID: 38206553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC35E3 identified as a target of novel‑m1061‑5p via microRNA profiling of patients with cardiovascular disease.
    Gao F; Wang FG; Lyu RR; Xue F; Zhang J; Huo R
    Mol Med Rep; 2018 Apr; 17(4):5159-5167. PubMed ID: 29393345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.